skathire Profile Banner
Sek Kathiresan MD Profile
Sek Kathiresan MD

@skathire

Followers
30K
Following
50K
Media
4K
Statuses
25K

CEO @VerveTx $VERV; Imagine if a one-time treatment led to permanent lowering of LDL cholesterol: that’s what we are developing to treat heart attack

Joined July 2012
Don't wanna be here? Send us removal request.
@skathire
Sek Kathiresan MD
4 years
What vaccinations are starting to allow: 🤗
Tweet media one
69
265
3K
@skathire
Sek Kathiresan MD
7 years
Best guide on writing a scientific paper (ever?). Useful to read before each attempt to write.
Tweet media one
25
1K
3K
@skathire
Sek Kathiresan MD
6 years
Astounding fact I learned today:. Weight of average adult US male. 1960: 166 pounds.2002: 191 pounds . 😬.
234
635
2K
@skathire
Sek Kathiresan MD
5 years
As a cardiology consultant in the hospital, here’s my nomination for the heroes of the pandemic:. 1. Nurses in the ER.2. Nurses in the ICU.3. Nurses on the floor.4. Nurses in the dialysis clinic.5. Nurses in the. .
64
368
2K
@skathire
Sek Kathiresan MD
5 years
Born in Tirupattur, India.Immigrated to Pittsburgh, PA 1980.Professor Medicine @harvardmed .CEO @VerveTx . Assimilated.
@LaurenWitzkeDE
Lauren Witzke
5 years
Most third-world migrants can not assimilate into civil societies. Prove me wrong.
25
116
1K
@skathire
Sek Kathiresan MD
5 years
Proof-of-concept for an entire new way to treat heart attack: .a gene editing medicine, .administered once in life, .safely turn off a gene --> .permanently lower cholesterol or triglycerides. A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys
49
491
1K
@skathire
Sek Kathiresan MD
4 years
Amazing. Once weekly injection, 30lbs average weight loss. Phenomenal results for a medicine to treat obesity. Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM
Tweet media one
50
270
1K
@skathire
Sek Kathiresan MD
2 years
Can we precisely rewrite the genetic code - make a single DNA spelling change - in the liver of a human being for clinical effect?. YES!. Scientific milestone: VERVE-101 provides first proof-of-concept for in vivo DNA base editing in humans . Clinical implication: It’s early
Tweet media one
41
246
1K
@skathire
Sek Kathiresan MD
3 years
Wow, say it with me:. “a functional cure” for sickle cell disease with CRISPR gene editing . All 31 patients with severe SCD, no vaso-occlusive crises (f/u 2 to 32 mos). Similar durability and efficacy for beta-thal. 👏🏽👏🏽👏🏽 .@CRISPRTX .@VertexPharma .
Tweet media one
21
207
934
@skathire
Sek Kathiresan MD
4 years
Does chronic disease need to equal chronic care? No. 👇in @Nature from @VerveTx . One-time base editing Rx (in vivo liver), .durable⬇️LDL-C . In monkeys: . *⬇️90% PCSK9,⬇️60% LDL-C, now out to 10 mos. * VERVE-101: efficacy at LNP doses as low as 0.5 mg/kg.
Tweet media one
32
263
896
@skathire
Sek Kathiresan MD
6 years
Met with postdoc keen on staying in academia & applying for faculty jobs. I asked: "Have you put together a Description of Research Activities?". 👇🏽mine from April 2007 as I was just finishing my research training & applying for research faculty positions. Some thoughts. thread.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
23
241
855
@skathire
Sek Kathiresan MD
4 years
Kindergarten (2008). College drop off (2021). 😭
Tweet media one
Tweet media two
36
6
863
@skathire
Sek Kathiresan MD
8 years
Wow, some good news from 2016. The development of a vaccine with 100% efficacy against Ebola.
Tweet media one
3
358
765
@skathire
Sek Kathiresan MD
7 years
From Viramathi, Tamilnadu, India. to Espe Elementary School @CityPGH ('80). to 👇. What a thrilling ride in this amazing country 🇺🇸. Grateful to my family.
Tweet media one
102
37
792
@skathire
Sek Kathiresan MD
2 years
Wow, wow, wow!. In SELECT trial of patients with obesity (mean BMI 33, n>17,000) & prior atherosclerotic cardiovascular disease (but no diabetes),. GLP-1 agonist semaglutide 2.4mg once-weekly. reduced risk of CV death, heart attack, or stroke (RRR 20%).
Tweet media one
Tweet media two
31
220
794
@skathire
Sek Kathiresan MD
4 years
One-time treatment, permanent lowering of LDL, really?. Yes! . Today, we @VerveTx announce durable lowering of blood. PCKS9 protein (⬇️89%).&.LDL-C (⬇️61%). out to 6+ months after a one-time gene editing treatment in non-human primates . #JPM2021.
Tweet media one
31
176
746
@skathire
Sek Kathiresan MD
4 years
Wow, antiviral pill taken within 3d of symptoms COVID: 89% reduction in hospitalization or death. Another @pfizer home run!. Protease inhibitor originally developed for SARS-Cov1 in 2003 and now repurposed!.
Tweet media one
48
208
665
@skathire
Sek Kathiresan MD
5 years
IMHO, biggest problem in biomedical science literature . 👇🏽. Insane level of focus on "novelty" over reproducibility/"incremental" progress
Tweet media one
16
93
580
@skathire
Sek Kathiresan MD
4 years
A home run!. @intelliatweets shows for first time in humans that in vivo liver gene editing (CRISPR-Cas9 mRNA + guide RNA packaged in a lipid nanoparticle). is going to work (REALLY WELL). At dose of just 0.3 mg/kg in 3 humans, .plasma TTR reductions:. 80%, 84%, & 96%. No AEs. 😳
Tweet media one
22
168
610
@skathire
Sek Kathiresan MD
6 years
News:. After 22y @MassGeneralNews @broadinstitute understanding risk & resistance to heart attack,. I am moving to new role as CEO @VerveTx - a biotech we have founded . to develop gene editing Rx that permanently reduce risk of coronary disease in adults.
Tweet media one
100
91
600
@skathire
Sek Kathiresan MD
3 years
After 24y as a practicing physician @MassGeneralNews. 😢
Tweet media one
26
11
568
@skathire
Sek Kathiresan MD
5 years
Humanity. Thank you. 🙏🏽. A San Francisco Doctor Answering the Call to New York -
10
99
486
@skathire
Sek Kathiresan MD
5 years
29,829 base pairs of RNA . can shut down the world. #SARSCoV2.
11
112
516
@skathire
Sek Kathiresan MD
6 years
Want something "unredacted" to read today. See here Why am I so heavy?. Obesity largely viewed as disease of willpower or poor lifestyle choices .BUT…our research out today shows:. 1. Genetics plays a large role in how heavy one gets.
Tweet media one
19
249
490
@skathire
Sek Kathiresan MD
5 years
Best news in months: . @Regeneron "its scientists have now isolated hundreds of antibodies that neutralize virus, & they’re sorting through them — as well as antibodies isolated from ppl who have recovered from COVID-19 — to find best 2 with which to create a cocktail treatment".
@megtirrell
Meg Tirrell
5 years
Regeneron's sped up its timeline for human trials of antibody therapy for #COVID19 by a couple months. Now aims to have doses for testing by early summer. George Yancopoulos: "There are always so many moving parts, but we’re hitting our best timelines"
5
141
482
@skathire
Sek Kathiresan MD
2 years
Thrilled to announce that @US_FDA has cleared our. *investigational new drug (IND)* application. for VERVE-101. FDA reviewed our hold response which included:.1. interim clinical data from the ongoing heart-1 trial currently being conducted ex-U.S. 2. pre-clinical data to address
Tweet media one
23
77
485
@skathire
Sek Kathiresan MD
5 years
He would have been 50 today. We lost him to a heart attack at 42. Working toward a future with fewer such losses. 🙏🏽
Tweet media one
21
17
482
@skathire
Sek Kathiresan MD
8 years
Wow. Every scientist should read. Ten simple rules for structuring papers
Tweet media one
2
285
454
@skathire
Sek Kathiresan MD
6 years
1st day, new job 👇🏽. 1st new employer in 22y. Nervous 😬.Super excited 😃.🙏🏽
Tweet media one
Tweet media two
19
11
423
@skathire
Sek Kathiresan MD
4 years
Quite awesome to ring the closing bell @nasdaq today on behalf of @VerveTx
Tweet media one
Tweet media two
18
13
411
@skathire
Sek Kathiresan MD
5 years
After being told of BRCA1 mutation, .up to 50% women opt for prophylactic mastectomy. Should this be so?. For "monogenic" forms breast ca, colorectal ca, & heart attack, we find polygenic background powerfully modifies risk. New on @medrxivpreprint .
Tweet media one
15
204
408
@skathire
Sek Kathiresan MD
3 years
Wow (and a double Wow!). *52 lb* weight loss (22.5%) . at highest dose of tirzepatide (a dual GLP-1 receptor / GIP receptor agonist from @LillyPad). GLP-1 class truly going to revolutionize the treatment of obesity!!!.
15
100
417
@skathire
Sek Kathiresan MD
3 years
Proudest personal accomplishment (over 5y). 😊
Tweet media one
32
1
405
@skathire
Sek Kathiresan MD
6 years
Quite embarrassing for @JAMA to continue to publish these horribly confounded nutritional epidemiology studies.
@JAMA_current
JAMA
6 years
In this pooled US cohort study, consumption of dietary cholesterol or eggs was associated with higher risk of incident CVD and all-cause mortality in a dose-response manner #ACC19.
16
87
367
@skathire
Sek Kathiresan MD
3 years
So, you weigh 250lb and want to lose 50lb. Can you do so safely with a once-a-week medicine?. Looks like tirzepatide will do the trick. Amazing!.
Tweet media one
11
66
375
@skathire
Sek Kathiresan MD
3 years
Ten years ago today, we lost him to complications of a heart attack. 🙏🏽. Working daily @VerveTx to make such tragedies less likely in future.
Tweet media one
11
6
367
@skathire
Sek Kathiresan MD
5 years
25 years.9,125 days.219,000 hours.13 million minutes.3 loved children.Lots of joy, some sorrow.Much laughter. Happy Anniversary Neela 😘🙏🏽
Tweet media one
17
1
346
@skathire
Sek Kathiresan MD
2 years
Idea: 2016.Company: 2018.NHP data: 2020.1st patient dosed: 2022. 1st human data for in vivo liver base editing in patients with heterozygous familial hypercholesterolemia and ASCVD . 👇🏽. @American_Heart .@VerveTx .$VERV. Stay tuned!
Tweet media one
17
44
356
@skathire
Sek Kathiresan MD
4 years
“These are stunning results,” says gene editing researcher and cardiologist Kiran Musunuru of the University of Pennsylvania, who was not involved in the trial. “It exceeds all my expectations.”
4
80
345
@skathire
Sek Kathiresan MD
5 years
@StevenSalzberg1 Wow @StevenSalzberg1. So much respect for this thoughtful response to the feedback. Simply wonderful example you are setting. 👍🏽👏🏽👌🏽.
2
12
322
@skathire
Sek Kathiresan MD
4 years
9 years ago today (after a heart attack). May he RIP. May we develop a solution to avert similar tragedies. 🙏
Tweet media one
23
4
346
@skathire
Sek Kathiresan MD
7 years
When listening to a new consult presentation, 2 things I would love to hear *first*:.1. reason for consult.2. what brought pt to hospital. What I hear first most often:.82yo with CKD on HD, T2D, AAA s/p repair, s/p CABG, hyperlipidemia, HFrEF, PAF on Xarelto, COPD on home O2. .
33
89
346
@skathire
Sek Kathiresan MD
7 years
Intense hunt by biotech (i.e. Calico) & billionaires to promote lifespan (healthy aging). Here, a genetic study reveals the secret: avoid a heart attack!. Most gene variants identified for lifespan are just common alleles *protective* for heart attack.
Tweet media one
11
134
338
@skathire
Sek Kathiresan MD
5 years
30 min physical activity, at least 5 days a week. How?. Found a parking spot 15 min walk from office. 😊. Happy, healthy 2020 everyone!.
12
23
324
@skathire
Sek Kathiresan MD
2 years
Wowza!. Losing 20lbs with GLP-1 agonist (semaglutide) . averts heart attacks/strokes .and .saves lives. (in patients who are overweight, without diabetes but with pre-existing atherosclerotic cardiovascular disease)
Tweet media one
11
78
332
@skathire
Sek Kathiresan MD
2 years
"healthy", then heart attack. Why? . Cool new study sheds light: . *9500 asymptomatic folks .*Test each with coronary CT angiogram (L) .*follow over time (R) . 46% - atleast some heart artery blockages . 5% - obstructive & extensive blockages! . Lots heart disease under radar
Tweet media one
21
100
326
@skathire
Sek Kathiresan MD
7 years
Grateful to @American_Heart for this wonderful honor - the Joseph A. Vita Award. I had the opportunity to work with Dr. Vita as fellow at the Framingham Heart Study; he was a wonderful man and a terrific scientist.
@HeartNews
American Heart News
7 years
Harvard scientist gets American Heart Association award for findings of inherited basis for cardiovascular disorders #AHA18.
Tweet media one
29
34
317
@skathire
Sek Kathiresan MD
2 years
New GLP1 Agonist orfoglipron.- once daily.- oral.- non-peptide.- no food or water restriction. 2 Phase 2 trials. Weight: up to 14.7% weight loss.T2D: up to 2.1% hemoglobin A1C reduction. Spectacular new option in the works.
Tweet media one
11
83
329
@skathire
Sek Kathiresan MD
8 years
Tweeps,.Thank you very much for kind words. Grateful to my family, mentors, trainees, institutions, and to this great country. From immigration 1980 with my brother (L) to .#AHA17 honor of our scientific contributions yesterday (R). A testament to power of opportunity in 🇺🇸
Tweet media one
Tweet media two
22
72
312
@skathire
Sek Kathiresan MD
4 years
Best news of day (even better than event in DC). Preliminary study from Sahin of @BioNTech_Group . @pfizer @BioNTech_Group vaccine induced neutralizing antibody response to UK variant similar to wild-type COVID virus. 👍🏽.
Tweet media one
Tweet media two
8
91
299
@skathire
Sek Kathiresan MD
3 years
@ashishkjha @bijans Ashish, . once we get through this wave (let's say end Feb), I do wonder if we need to change our thinking re testing. For endemic viruses (eg Flu), testing is typically done in people with symptoms (and usually just severe symptoms).
11
5
319
@skathire
Sek Kathiresan MD
4 years
Having led company from my basement for the last 9 months 😳,. nice to visit our new @VerveTx offices in 500 Tech Square for first time. 👌🏽. @kendallnow
Tweet media one
Tweet media two
Tweet media three
Tweet media four
15
3
312
@skathire
Sek Kathiresan MD
6 years
An oral drug which:.1. leads to meaningful weight loss.2. lowers all-cause mortality ~50%.3. lowers CV mortality.4. lowers hgA1C. Wow!. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM
Tweet media one
Tweet media two
17
100
301
@skathire
Sek Kathiresan MD
3 years
2018: @VerveTx founded with concept of one-time Rx to lower LDL as low as possible for as long as possible. Today: we are announcing . dosing of *first patient* with VERVE-101,. an in vivo CRISPR base editing medicine. 🙏 to patient volunteer. $VERV.
18
39
305
@skathire
Sek Kathiresan MD
6 years
👇🏽 what I hope will be our most impactful discovery to date. An enzyme whose loss of function lowers blood cholesterol & *protects* against fatty liver & cirrhosis. Kudos to @connoremdin whose clever analysis of public data (@ukbiobank) led to observation.
Tweet media one
5
121
289
@skathire
Sek Kathiresan MD
2 years
If LDL⬇️for a long time, really hard to get heart attack. Cool new evidence. Some lucky people born with DNA variation that naturally lowers LDL . ~50 mg/dl⬇️LDL, lifelong.&.risk for heart attack/death is ~50%⬇️!. So, for every 1 mg/dl⬇️LDL lifelong, .~1%⬇️risk heart attack/death
Tweet media one
15
81
295
@skathire
Sek Kathiresan MD
7 years
Quite an awesome email to wake up to:. About $10M worth of data to be given to you for free .*and* .the data generator is asking for input on file formats. 👏🏽👏🏽 @uk_biobank - emerging as the world standard for human biology research and open data. 👇🏽
Tweet media one
7
101
272
@skathire
Sek Kathiresan MD
7 years
Unbelievable. 😱 . The famous ‘Mediterranean diet’ is awesome study seems to have had serious randomization issues affecting >20% enrolled participants. Retracted and republished! .
24
182
285
@skathire
Sek Kathiresan MD
5 years
One minute: they're born. Next: dinner after touring @nyuniversity . Children, joy.
Tweet media one
10
4
271
@skathire
Sek Kathiresan MD
6 years
OK. For all the people who think these trends are because the US has become taller:. 🤦. average height US. 1960: 5ft 8in (male); 5ft 3in (female).2002: 5ft 9in (male); 5ft 4in (female).
18
33
268
@skathire
Sek Kathiresan MD
7 years
What is inherited basis for heart attack?. A new quantitative (genome-wide polygenic score) that captures inherited liability to heart attack. Normal distribution in population. For those in top 8% of scores, 3-4-fold higher risk than all others.
Tweet media one
11
139
271
@skathire
Sek Kathiresan MD
8 years
Thank you Ken Frazier @Merck, speaking for many of us.
@Merck
Merck
8 years
Tweet media one
7
79
238
@skathire
Sek Kathiresan MD
6 years
Your first love: food you grew up on!. 👇🏽👌🏽 😋
Tweet media one
23
10
267
@skathire
Sek Kathiresan MD
4 years
May all your days be like 👇🏽. 😊
Tweet media one
17
5
270
@skathire
Sek Kathiresan MD
4 years
If you develop a once-&-done gene editing med to durably lower LDL cholesterol & Rx heart attack, what do you need?. Capital . Today, @VerveTx announces Series B fund raise of $94M led by @Wellington_Mgmt & co-led by @cascapital, with 9 new investors. 🙏.
Tweet media one
24
17
268
@skathire
Sek Kathiresan MD
4 years
Often get asked about "founding story" @VerveTx . None other than @American_Heart "One Brave Idea" competition to cure coronary heart disease. Our submission from April 2016 👇. Idea incubated with @GVteam '16-'18.Series A funding August '18. 1st patient dosing - planned 2022
Tweet media one
Tweet media two
12
34
270
@skathire
Sek Kathiresan MD
3 years
South Asians: about 1/4 of world population. Representation in genetic studies: almost 0. 😕.
@EricTopol
Eric Topol
3 years
The remarkable and persistent lack of diversity in genomic studies .@NatureMedicine @SFatumo @KKuchenbaecker .@tchikowore1 @Ayub1985 @genetisaur.And a plan to fix it @LHSTM @UCL @uclbiosciences @MRC_Uganda @H3Africa @PGCgenetics @PRSdiversity @H3ABioNet
Tweet media one
11
73
263
@skathire
Sek Kathiresan MD
4 years
k thru 12 🎓 in the blink of an eye. Congrats @ninakathiresan . 🥲👏🏽
Tweet media one
Tweet media two
11
1
258
@skathire
Sek Kathiresan MD
5 years
"Pfizer, Moderna, Johnson & Johnson, GlaxoSmithKline, Sanofi and possibly others". Drugmakers are planning a public pledge to not send any Covid-19 vaccine to the FDA for review without extensive safety and efficacy data, sources say via @business.
9
83
229
@skathire
Sek Kathiresan MD
5 years
You thought taking off your shoes was annoying. How about a quick blood test before flying? 😱. Emirates becomes first airline to conduct on-site rapid COVID-19 tests for passengers
13
81
245
@skathire
Sek Kathiresan MD
6 years
1st patient ever treated by CRISPR gene editing medicine: for sickle cell disease . 👏🏽👇🏽🙏🏽. ⁦@VertexPharma⁩.⁦@CRISPRTX⁩. CRISPR Gene-Editing Tool: 1st Patient With Genetic Disorder Treated In U.S. : Shots - Health News : NPR
3
97
244
@skathire
Sek Kathiresan MD
4 years
What’s the best text a son can get from elderly parents during the pandemic?. 👇🏽👌🏽🙏🏽
Tweet media one
10
2
236
@skathire
Sek Kathiresan MD
4 years
👇🏽. Verve Therapeutics Announces Pricing of Initial Public Offering | Business Wire
38
13
251
@skathire
Sek Kathiresan MD
2 years
Nice reminder today:. Getting LDL cholesterol. as low as possible for as long as possible . is the best way to treat or prevent heart attack.
21
28
244
@skathire
Sek Kathiresan MD
7 years
👇23 years ago today in Tarrytown, NY. Grateful to have found a wonderful partner to share the highs (and lows) of life.
Tweet media one
19
0
238
@skathire
Sek Kathiresan MD
5 years
Happy Diwali 2020! 🪔. Diwali is a Hindu holiday which symbolizes the spiritual victory of light over darkness, good over evil, and knowledge over ignorance.
8
24
233
@skathire
Sek Kathiresan MD
6 years
Amazing!. “After the CRISPR therapy, Gray’s total hemoglobin reached normal levels; of which 47% was fetal hemoglobin. It’s thought that a fetal hemoglobin level of 25%-30% is sufficient to “cure” a patient with sickle cell disease.“. New era of single, transformative therapies.
@adamfeuerstein
Adam Feuerstein ✡️
6 years
$VRTX $CRSP news! —> First CRISPR treatment for blood diseases shows early benefits in two patients via @sxbegle and me.
5
95
233
@skathire
Sek Kathiresan MD
1 year
A new era of CRISPR-based medicines with single treatments that offer curative potential!. Kudos to ⁦@VertexPharma⁩ and ⁦@CRISPRTX⁩. FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease | FDA
7
57
244
@skathire
Sek Kathiresan MD
5 years
Grateful to announce👇🏽. Thanks to @GVteam (lead), @rtnarch, @FPrimeCapital, Biomatics, Partners Innovation Fund. and 2 new investors Wellington & @cascapital . Verve raises another $63m to develop gene-editing treatment for heart disease via @BostonGlobe.
29
21
240
@skathire
Sek Kathiresan MD
2 years
👇🏽. First CRISPR-based medicine approved . Amazing new option for patients with sickle-cell disease & b-thal. MHRA authorises world-first gene therapy that aims to cure sickle-cell disease and transfusion-dependent β-thalassemia -
3
56
243
@skathire
Sek Kathiresan MD
5 years
Terrific must-read @TheLancet on COVID-19 epidemiology. Did you know: . "A simple calculation gives fraction likely to be infected without mitigation. This fraction is roughly.1–1/R0. With R0 values for COVID-19 in China around 2·5. ~60% of population would become.infected."
Tweet media one
Tweet media two
Tweet media three
Tweet media four
4
111
237
@skathire
Sek Kathiresan MD
4 years
And it’s happening. Surreal.😊. @VerveTx . Amazing team developing gene editing medicines to solve the world’s leading of death, atherosclerotic cardiovascular disease
Tweet media one
Tweet media two
21
9
239
@skathire
Sek Kathiresan MD
5 years
0.3% of a very large number is a very large number. That’s it.
4
19
221
@skathire
Sek Kathiresan MD
4 years
Cool new study from @Regeneron . Identification loss-of-function variants in GPR75 gene that protect against obesity. Het LoF carriers about 12lb lighter. Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity
5
87
231
@skathire
Sek Kathiresan MD
3 years
In @CircAHA, we publish today pre-clinical data for VERVE-101. Of note, @American_Heart tells us that for Scientific Sessions '22, this abstract the highest ranked one of all submitted from U.S. #AHA22 . Press release: Paper:
Tweet media one
2
60
234
@skathire
Sek Kathiresan MD
4 years
Mom visiting means…👇🏽😋👌🏽
19
1
235
@skathire
Sek Kathiresan MD
5 years
@ScottGottliebMD key contributor to the sentinel surveillance of COVID-19 in Seattle was the Seattle Flu Study, a collaborative effort by the Brotman Baty Institute, UW Medicine, Fred Hutch, and Seattle Children’s. cc: @JShendure head Brotman Baty.
5
36
214
@skathire
Sek Kathiresan MD
5 years
👇🏽a cure for sickle cell seems to be coming. Wow.
@endpts
Endpoints News
5 years
Vertex and CRISPR Therapeutics showed their experimental therapy kept two sickle patients from experiencing painful incidences and kept patients with another blood disorder from requiring transfusions.
3
26
229
@skathire
Sek Kathiresan MD
5 years
Over-rated: genius. Under-rated: preparedness.
3
42
213
@skathire
Sek Kathiresan MD
3 years
@VerveTx is thrilled to announce. *Clearance* of first VERVE-101 clinical trial application (CTA) . 🎉🎉. Expect to treat 1st patient with HetFH in mid-2022. Expect clinical data in 2023. As part of planned global regulatory strategy,.CTA in UK & IND in US are up next
Tweet media one
6
23
231
@skathire
Sek Kathiresan MD
3 years
So, I grew up in Tamilnadu, a state in southern India. Imagine my delight when my father sent me (L). @VerveTx shows up in Dinamalar, largest Tamil daily paper 😀. article (L), my father's translation (R). boxed in white is "CRISPR gene editing" in Tamil!.
Tweet media one
Tweet media two
11
4
233
@skathire
Sek Kathiresan MD
5 years
#HappyFathersDay2020 everyone. 👇🏽certainly the greatest joy in my life.
Tweet media one
3
1
228
@skathire
Sek Kathiresan MD
4 years
So, three teenagers in the house as of today 😃😬. Happy 13th Devan. Boy, they grow up fast.
Tweet media one
Tweet media two
9
4
233
@skathire
Sek Kathiresan MD
3 years
GLP-1 agonists do seem to be the *miracle* drug for the 21st century obesity epidemic:. Lose weight, lower glucose, lower triglycerides, lower BP . *AND*. Lower risk of heart attack. Oh, also, potential benefits re NASH and sleep apnea.
@DanielJDrucker
Daniel J Drucker
3 years
As @LillyPad invests heavily in a GLP-1 based pipeline for #T2D #obesity #NASH Dulaglutide annualizing at 7.3 B USD
Tweet media one
Tweet media two
11
47
232
@skathire
Sek Kathiresan MD
6 years
@TeamJuJu You’ll be smiling again soon like 👇🏽when we ran into you in Barcelona!. Keep your head up.
Tweet media one
1
2
226
@skathire
Sek Kathiresan MD
1 year
Viramathi, Tamil Nadu. My roots.
Tweet media one
7
5
228
@skathire
Sek Kathiresan MD
2 years
In first test for base editing, Verve’s one-time treatment lowers cholesterol levels in patients via @statnews.
11
36
233
@skathire
Sek Kathiresan MD
2 years
We are thrilled to gain @EliLillyandCo as a new partner for @VerveTx PCSK9 & ANGPTL3 programs👇. Lilly has purchased from @BeamTx all of their previously held product rights in PCSK9 & ANGPTL3 programs for a $600M total potential deal value. For the PCSK9 & ANGPTL3 product
Tweet media one
7
17
223
@skathire
Sek Kathiresan MD
4 years
2 powerful relationships in medicine:. (L) For every 39 mg/dL pharmacologic LDL lowering ~5y,.⬇️21% in CV events .(regardless starting LDL). Now, we have:. (R) For every 5 mmHg pharmacologic BP lowering ~4y,.⬇️10% in CV events.(regardless starting BP)
Tweet media one
Tweet media two
8
87
234